Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
29 Dec 2025
Hidradenitis Suppurativa Biologics Show Early Differences
Bimekizumab showed the strongest short-term efficacy among hidradenitis suppurativa biologics in trials assessed at Week 12 to 16.
29 Dec 2025
Granulosa Cell DNA Methylation Tied to Accelerated Aging Pace
Lower ovarian reserve was significantly associated with accelerated pace of aging and higher methylation risk scores for cardiovascular and metabolic disease.
29 Dec 2025
Serum CXCL6 Biomarker Signals AAV-ILD Progression Risk
Baseline serum CXCL6 levels distinguished patients with ANCA-ILD and independently predicted ILD progression during follow up later.
29 Dec 2025
Vixarelimab Shows Sustained Itch and Lesion Improvement in Prurigo Nodularis
Vixarelimab significantly reduced itch severity and improved skin clearance in patients with prurigo nodularis in a phase 2b randomized clinical trial.
29 Dec 2025
EMJ Podcast: 2025 Top 10 Episodes
In this special countdown episode, the EMJ Podcast team looks back at the 10 highest-performing episodes of 2025. Spanning neurology…
28 Dec 2025
New Epinephrine Guidelines for Non-medics in Acute Allergic Reactions
International panel of anaphylaxis experts develops guidance for non-medical personnel to correctly identify patients with acute allergic reactions that require epinephrine administration.
28 Dec 2025
Robotic Assisted Versus Laparoscopic Surgery in Obese Colorectal Cancer
Robotic surgery shortened hospital stay versus laparoscopy for obese patients with colorectal cancer, with comparable safety overall.
28 Dec 2025
APOC1 and NOP16 Show Promise as Early Prostate Cancer Biomarkers
A new study identifies APOC1 and NOP16 as potential prostate cancer biomarkers that may improve early diagnosis and complement current PSA testing.
28 Dec 2025
Most Teens Show Mental Health Resilience
Most adolescents maintained stable mental health through the COVID-19 pandemic, despite widespread concerns about rising depression, according to a large US cohort study.
28 Dec 2025
Neurodisability Linked to More Primary School Absences
Children with neurodisability had increased hospital admissions and school absences across primary school, nationwide records show.
←
1
2
3
…
7
8
9
10
11
12
13
…
1,436
1,437
1,438
→
We’ve noticed you’re accessing
from
North/South America.
View
View